IDPC provides key recommendations on how the expert panel can meaningfully engage with civil society, directly affected communities, Indigenous Peoples and youth within their work.
This joint civil society submission warns that restrictive laws and funding barriers are undermining the rights and operations of organisations supporting people who use drugs and other marginalised communities.
C-EHRN highlights shifting drug trends across Europe, noting the rising prevalence of polydrug use, potent synthetic substances, and the critical need for adapted harm reduction services.
The VNGOC and 125 co-signing organisations have issued an open letter to the UN, calling for urgent reforms to address procedural barriers that effectively exclude civil society.
The Drug Policy Alliance says shifting from fear-based narratives to positive, public health messaging is key to building safer and healthier communities.
Mainline's closure due to loss of international and domestic funding highlights growing concerns over the sustainability of harm reduction services globally.
Outgoing IDPC Executive Director, Ann Fordham reflects on the evolution of global drug policy, the growth of civil society advocacy, and the urgent need to defend hard-won progress.
The event brings together organisations, practitioners and communities to reaffirm the foundations of harm reduction in the face of stigma and misinformation.
Ten years after the 2016 UNGASS, punitive drug policies remain dominant globally, with human rights violations, rising deaths and shrinking civic space undermining promises of reform.
